Russell Investments Group
EVH icon

Russell Investments Group’s Evolent Health EVH Stock Holding History

Russell Investments Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
203,369
+66,428
+49% +$255K ﹤0.01% 2413
2026
Q1 		$312K Sell
136,941
-7,563
-5% -$24K ﹤0.01% 2689
2025
Q4 		$578K Sell
144,504
-6,749
-4% -$37.5K ﹤0.01% 2435
2025
Q3 		$1.28M Sell
151,253
-5,535
-4% -$53.7K ﹤0.01% 2094
2025
Q2 		$1.77M Buy
156,788
+58,683
+60% +$539K ﹤0.01% 1782
2025
Q1 		$929K Buy
98,105
+21,826
+29% +$220K ﹤0.01% 2063
2024
Q4 		$858K Buy
76,279
+16,068
+27% +$282K ﹤0.01% 2077
2024
Q3 		$1.7M Sell
60,211
-18,763
-24% -$484K ﹤0.01% 1772
2024
Q2 		$1.51M Sell
78,974
-16,815
-18% -$429K ﹤0.01% 1779
2024
Q1 		$3.14M Sell
95,789
-2,299
-2% -$73.4K 0.01% 1393
2023
Q4 		$3.24M Buy
98,088
+17,339
+21% +$491K 0.01% 1351
2023
Q3 		$2.2M Buy
80,749
+7,161
+10% +$199K ﹤0.01% 1486
2023
Q2 		$2.23M Sell
73,588
-3,817
-5% -$123K ﹤0.01% 1489
2023
Q1 		$2.51M Sell
77,405
-26,128
-25% -$826K ﹤0.01% 1443
2022
Q4 		$2.91M Sell
103,533
-270,711
-72% -$7.76M 0.01% 1365
2022
Q3 		$13.4M Buy
374,244
+336,281
+886% +$11.8M 0.03% 638
2022
Q2 		$1.17M Buy
37,963
+18,532
+95% +$540K ﹤0.01% 1887
2022
Q1 		$627K Sell
19,431
-8,286
-30% -$217K ﹤0.01% 2153
2021
Q4 		$766K Buy
27,717
+12,427
+81% +$356K ﹤0.01% 2287
2021
Q3 		$473K Sell
15,290
-12,407
-45% -$298K ﹤0.01% 2484
2021
Q2 		$584K Buy
27,697
+14,420
+109% +$289K ﹤0.01% 2528
2021
Q1 		$268K Buy
+13,277
New +$252K ﹤0.01% 2753
2020
Q2 		– Sell
-18,557
Closed -$100K – 3145
2020
Q1 		$100K Buy
+18,557
New +$166K ﹤0.01% 2732
2019
Q3 		– Sell
-59,414
Closed -$472K – 3041
2019
Q2 		$472K Buy
+59,414
New +$703K ﹤0.01% 2282
2017
Q3 		– Sell
-692,548
Closed -$17.6M – 2962
2017
Q2 		$17.6M Buy
692,548
+524,139
+311% +$12.6M 0.03% 659
2017
Q1 		$3.75M Buy
168,409
+88,830
+112% +$1.71M 0.01% 1388
2016
Q4 		$1.18M Buy
+79,579
New +$1.57M ﹤0.01% 2095

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Russell Investments Group's EVH Position: Q2 2026 in Review

Russell Investments Group increased its Evolent Health (EVH) stake by 49% in Q2 2026, buying an estimated $255K and bringing the position to 203,369 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2413.

Russell Investments Group first reported a position in EVH in Q4 2016 and has held it in 27 quarters since. The position peaked at $17.6M in Q2 2017. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Russell Investments Group held 203,369 shares of Evolent Health worth $1.1M as of Q2 2026.
  • Russell Investments Group bought 66,428 Evolent Health shares in Q2 2026, an estimated $255K.
  • Evolent Health made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2413 holding.
  • Russell Investments Group first reported a position in Evolent Health in Q4 2016 and has held it in 27 quarters since.
  • Russell Investments Group's Evolent Health position peaked at $17.6M in Q2 2017.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.